FedEx reported Q1 earnings on September 28 and managed a small positive price reaction, but the recovery has stalled quickly: the stock closed Tuesday at $287.47, down 2.9% on the week and 13% over the past month, still well below the levels where bulls had been comfortable holding.
The earnings print itself produced a one-day gain of 0.6%, a thin result after a month-long selloff of that magnitude. The prior quarter told a starker story, with FDX falling 3.6% on the day and 4.8% over the following week. That pattern, a modest beat followed by a muted relief rally rather than a sustained recovery, captures the market's current disposition toward the stock: willing to acknowledge progress, not yet willing to reprice it. The next earnings event is scheduled for October 28, giving investors roughly four weeks to decide whether the Q1 result changes the fundamental narrative.
Positioning in the lending market continues to offer no signal of a building short thesis. Borrow availability remains effectively uncapped, with 235 million shares available against a short position of roughly 4.5 million. Short interest is 1.9% of the free float, down about 9.5% on the week and down nearly 12% over the past month as some bears that had been cautiously building into the earnings report covered afterward. Cost to borrow has risen 28% on the week to 0.43%, which looks notable in percentage terms but remains low in absolute terms. The ORTEX short score of 32 sits in the lower half of the range, consistent with a stock where short sellers are watching but not crowding. The borrow market is loose; this is a story about fundamental uncertainty, not short-side pressure.
Options traders have also retreated from the more defensive posture they held heading into the earnings date. The put/call ratio is 0.87, just above its 20-day average of 0.81 and less than half a standard deviation elevated. As recently as September 22, the PCR was running above 0.95 with the stock pricing in a wider range of outcomes. The current reading reflects hedgers stepping back post-print rather than new conviction in either direction.
The Street's view is positive but has been quietly walking back its price ambitions. The consensus mean target is $355, implying roughly 24% upside from Tuesday's close. Evercore ISI nudged its target to $351 on September 28, maintaining an In-Line rating, a move that effectively signals comfort with the current range rather than renewed enthusiasm. JPMorgan, which held an Overweight, cut its target from $460 to $400 on September 8, a significant reduction that reflects a reset in expectations around the pace of margin improvement from the ground network integration. Several other firms, including UBS and Stifel, made comparable cuts in late June following the prior quarter's miss. Bulls point to the Freight separation optionality and the cost-reduction program as multi-year drivers; bears flag execution risk on the transformation, fuel cost sensitivity, and the drag from uncertain global trade volumes. The analyst recommendation differential factor ranks in the 93rd percentile, meaning the consensus skew toward positive ratings is unusually wide relative to history, though the string of target cuts suggests conviction is softer than the ratings alone imply. The trailing PE has compressed nearly 2.2 points over the past month to 14.3x, a valuation that looks undemanding if the cost program delivers.
Institutional ownership provides modest context. BlackRock added 1.98 million shares in the most recent reported period, bringing its stake to 8.8% of shares. The Frederick W. Smith estate holds 6.5%, essentially unchanged. On the 13D/G register, the most notable filing is Vanguard Group's disclosure showing its stake fell to zero from a prior 10% position, though Vanguard Capital Management filed separately at 6.75%. These are event-driven disclosures around the 5% threshold and stakes are as last disclosed, so the picture is incomplete. Insider activity over the past 90 days has been limited to routine option exercises and tax-withholding sales from directors, with no open-market buying.
What to watch in the four weeks before the October 28 print is whether the analyst community follows the JPMorgan target reset with further downward revisions, and whether the put/call ratio rebuilds toward the defensive readings seen in mid-September as the next earnings date approaches.
See the live data behind this article on ORTEX.
Open FDX on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
